IntelliGenome CRISPR Diagnostics Platform

Integrated platform for molecular diagnostic testing including PCR-based nucleic acid detection systems for infectious disease and genetic testing.

Integrated platform for molecular pathogen detection and genetic analysis. Supports PCR-based and sequencing-based diagnostic applications for infectious disease and genetic screening.

Advanced diagnostic system utilizing molecular biology techniques for infectious disease and genetic testing. Supports laboratory analysis with high sensitivity and specificity.

Fully automated molecular diagnostic system for infectious disease detection. Provides end-to-end automation from sample processing through result evaluation.

Comprehensive diagnostic instrument system for nucleic acid detection and analysis. Supports multiple molecular testing modalities including PCR and sequencing.

A molecular diagnostics platform utilizing multiplex real-time PCR technology for simultaneous detection of multiple pathogens. Core technology supporting clinical and research diagnostic applications.

Automated PCR analysis platform for molecular diagnostics and research applications. Provides high-throughput capabilities for nucleic acid amplification and detection. Designed for integration into diagnostic laboratory workflows.

Integrated system supporting development and optimization of diagnostic assays from initial design through manufacturing. Enables rapid prototyping and scaling of diagnostic solutions. Facilitates transition from concept to commercial production.

A molecular diagnostic platform for rapid nucleic acid testing. The system enables quick and accurate detection of infectious agents and genetic targets in clinical samples.

Genomtec’s platform technology enables fast and precise molecular analysis outside the laboratory environment without the need for qualified laboratory personnel. The solution utilises microfluidic technology and a proprietary lab-on-a-chip reaction card. Proprietary SNAAT® (Streamlined Nucleic Acid Amplification Technology) allows the detection of targeted DNA or RNA fragments in as little as 15 minutes, while maintaining effectiveness and performance comparable to currently used lab-based PCR methods. Genomtec serves the Clinical Diagnostics, Life Sciences, Veterinary, Food Safety, and Biosecurity markets. The company holds more than 5 patents and 3-5 trademarks.

Data-driven diagnostic platform providing single-cell resolution analysis for unprecedented disease insight and ultra-sensitive diagnostics. Enables discovery of hidden cellular biomarkers in disease states.

Comprehensive platform for developing and manufacturing medical diagnostic instruments. The platform enables creation of detection devices for clinical laboratory and point-of-care applications.